Trial intelligence / Profile preview

Dexmedetomidine vs Dexmedetomidine + Ketamine in Post Cardiac Surgery

NCT05218161Unknown

Sponsor
Chaudhry Pervaiz Elahi Institute of Cardiology
Start
Jan 2021
Primary completion
Feb 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of ketamine in hemodynamic instability (2 arms), sponsored by Chaudhry Pervaiz Elahi Institute of Cardiology. Primary endpoint: Hemodynamic stability at 6 months. Status: unknown.

02

Drugs

ketamine
03

Conditions

hemodynamic instability

Beyond the preview

Go deeper on NCT05218161.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05218161.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call